Blood Plasma Market Growth Analysis $54,787.67 Million By 2032 & CAGR: 7.2%

Blood Plasma Market Size Worth $54,787.67 Million By 2032 | CAGR: 7.2%

The global blood plasma market size is expected to reach USD 54,787.67 million by 2032, according to a new study by Polaris Market Research. The report “Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others); By Application; By End-Use; By Region; Segment Forecast, 2023- 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blood plasma market is experiencing substantial growth due to the increasing prevalence of severe blood disorders, notably Hemophilia and Thalassemia, impacting hundreds of newborns annually. Blood plasma, the fluid component of blood, plays a crucial role in transporting various blood constituents and is particularly in demand from individuals with blood type A.B. It is used in treating burn, shock, trauma, and clotting disorders, aiding in blood volume, shock prevention, and clotting support. Pharmaceutical companies utilize plasma for producing treatments for bleeding disorders and immune deficiencies.

The market's expansion is driven by government initiatives, growing public awareness, research and development efforts, healthcare sector expansion, an aging population, and increased adoption of plasma-derived products. Plasma-derived products like coagulation factor VIII and immunoglobulins are essential for managing blood-related disorders. Research and development in advanced plasma-derived products, strategic manufacturing, technological advancements, a substantial patient base, and increased healthcare expenditure all contribute to the market's positive trajectory during the 2022 to 2032 forecast period.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

The blood plasma market faces disruption from recombinant alternatives that offer treatments for various medical conditions without relying on human plasma. Biologically engineered proteins and clotting factors can be produced through recombinant technologies, reducing dependence on plasma. This competition can impact pricing and market share, as recombinant alternatives are perceived as safer, eliminating the risk of pathogen transmission associated with plasma-derived products in specific diseases and medical conditions.

Blood Plasma Market Report Highlights

  • Immunoglobulins dominated with 45.4% revenue share in 2022, serving vital roles in immune responses and treating autoimmune and immunodeficiency disorders.
  • Immunodeficiency Diseases segment accounted for 28.7% of revenue in 2022, primarily relying on blood plasma-derived products, like immunoglobulins, to manage various primary immunodeficiency disorders.
  • North America led the 2022 global market 45.5% share in supplying plasma-derived products, vital for international demand and public health preparedness.
  • The global key market players include Biotest AG, CSL, GC Biopharma Corp, Grifols, Intas Pharmaceuticals Ltd, Kedrion S.p.A., LFB, Octapharma AG, Sanquin, Takeda Pharmaceuticals

Polaris Market Research has segmented the Blood Plasma market report based on Type, Application, End-User, and region:

Blood Plasma, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others

Blood Plasma, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Hemophilia
  • Hypogammaglobinemia
  • Immunodeficiency Diseases
  • Von Willebrand’s Disease
  • Others

Blood Plasma, End-User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Clinics
  • Others

Blood Plasma, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Blood Plasma Market Report Scope

Report Attributes


Market size value in 2023

USD 29,421.48 million

Revenue forecast in 2032

USD 54,787.67 million


7.2% from 2022 – 2030

Base year


Historical data

2019 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD million and CAGR from 2023 to 2032

Segments covered

By Type, By Application, By End-Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation.

For Specific Research Requirements

Request for Customized Report

License and Pricing

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing